These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1324087)

  • 1. Effects of diabetes on stress-induced analgesia in mice.
    Kamei J; Kawashima N; Ohhashi Y; Kasuya Y
    Brain Res; 1992 May; 580(1-2):180-4. PubMed ID: 1324087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential mediation of cold water swim stress-induced antinociception by delta-opioid receptor subtypes in diabetic mice.
    Kamei J; Iwamoto Y; Hitosugi H; Misawa M; Nagase H; Kasuya Y
    Life Sci; 1994; 54(23):PL425-30. PubMed ID: 8196487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone-induced analgesia in diabetic mice.
    Kamei J; Kawashima N; Kasuya Y
    Eur J Pharmacol; 1992 Jan; 210(3):339-41. PubMed ID: 1319338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress-induced analgesia in mu-opioid receptor knockout mice reveals normal function of the delta-opioid receptor system.
    LaBuda CJ; Sora I; Uhl GR; Fuchs PN
    Brain Res; 2000 Jun; 869(1-2):1-5. PubMed ID: 10865052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinociceptive effect of oxycodone in diabetic mice.
    Nozaki C; Saitoh A; Tamura N; Kamei J
    Eur J Pharmacol; 2005 Nov; 524(1-3):75-9. PubMed ID: 16256106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delta-opiod receptor-mediated forced swimming stress-induced antinociception in the formalin test.
    Kamei J; Hitosugi H; Misawa M; Nagase H; Kasuya Y
    Psychopharmacology (Berl); 1993; 113(1):15-8. PubMed ID: 7862822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical analgesia produced by naloxone in diabetic mice is attributable to supersensitivity of delta-opioid receptors.
    Kamei J; Kawashima N; Kasuya Y
    Brain Res; 1992 Oct; 592(1-2):101-5. PubMed ID: 1450902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the antinociceptive effects of oxycodone in diabetic mice.
    Nozaki C; Saitoh A; Kamei J
    Eur J Pharmacol; 2006 Mar; 535(1-3):145-51. PubMed ID: 16533506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of diabetes on the morphine-induced Straub tail reaction in mice.
    Kamei J; Ohsawa M; Misawa M; Nagase H; Kasuya Y
    Neurosci Lett; 1994 Aug; 178(1):66-8. PubMed ID: 7816343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of mu1-opioid receptor on oxycodone-induced antinociception in diabetic mice.
    Nozaki C; Kamei J
    Eur J Pharmacol; 2007 Apr; 560(2-3):160-2. PubMed ID: 17292346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
    Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential involvement of opioid receptors in stress-induced antinociception caused by repeated exposure to forced walking stress in mice.
    Onodera K; Sakurada S; Furuta S; Yonezawa A; Arai K; Hayashi T; Katsuyama S; Sato T; Miyazaki S; Kisara K
    Pharmacology; 2000 Aug; 61(2):96-100. PubMed ID: 10940783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord.
    Wu HE; Thompson J; Sun HS; Leitermann RJ; Fujimoto JM; Tseng LF
    J Pharmacol Exp Ther; 2004 Jul; 310(1):240-6. PubMed ID: 14999057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analgesic effects of mu antagonists after naloxone non-reversible stress-induced analgesia.
    Sacerdote P; Mantegazza P; Panerai AE
    Brain Res; 1985 Dec; 359(1-2):34-8. PubMed ID: 3000523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of increased pain threshold by noise with central opioid neurons.
    Chen YF; Chiang HM; Tsai YT; Tsai HY
    Chin J Physiol; 2009 Apr; 52(2):93-8. PubMed ID: 19764344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of diabetes on the antinociceptive effect of (+/-)pentazocine in mice.
    Kamei J; Iwamoto Y; Misawa M; Nagase H; Kasuya Y
    Res Commun Chem Pathol Pharmacol; 1994 Apr; 84(1):105-10. PubMed ID: 8042002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid and nonopioid swim stress-induced analgesia: a parametric analysis in mice.
    Mogil JS; Sternberg WF; Balian H; Liebeskind JC; Sadowski B
    Physiol Behav; 1996 Jan; 59(1):123-32. PubMed ID: 8848471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediation of swim-stress antinociception by the opioid delta 2 receptor in the mouse.
    Vanderah TW; Wild KD; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1992 Jul; 262(1):190-7. PubMed ID: 1320682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracerebroventricular physostigmine-induced analgesia: enhancement by naloxone, beta-funaltrexamine and nor-binaltorphimine and antagonism by dynorphin A (1-17).
    Fujimoto JM; Rady JJ
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1045-52. PubMed ID: 2574738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses.
    McLaughlin JP; Marton-Popovici M; Chavkin C
    J Neurosci; 2003 Jul; 23(13):5674-83. PubMed ID: 12843270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.